Especially, Galectin9 can activate Dectin1 on macrophages to promote pancreatic carcinoma and peritumoral immune tolerance, and the Dectin1–Galectin9 axis plays a decisive role in the education of T cells toward immunogenic or tolerogenic phenotypes in PDA. This evidence concerns the gene CLEC7A and Patent ductus arteriosus.